{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:45:17Z","timestamp":1694637917070},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,9,11]],"date-time":"2009-09-11T00:00:00Z","timestamp":1252627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s11255-009-9634-x","type":"journal-article","created":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T10:29:46Z","timestamp":1252578586000},"page":"173-179","source":"Crossref","is-referenced-by-count":6,"title":["Statins and vitamin D: a friendly association in pre-dialysis patients"],"prefix":"10.1007","volume":"42","author":[{"given":"Pedro L.","family":"Neves","sequence":"first","affiliation":[]},{"given":"Anabela","family":"Malho","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Cabrita","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Pinho","sequence":"additional","affiliation":[]},{"given":"Alexandre","family":"Baptista","sequence":"additional","affiliation":[]},{"given":"Elsa","family":"Morgado","sequence":"additional","affiliation":[]},{"given":"Mar\u00edlia","family":"Fa\u00edsca","sequence":"additional","affiliation":[]},{"given":"Herm\u00ednio","family":"Carrasqueira","sequence":"additional","affiliation":[]},{"given":"Ana P.","family":"Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,9,11]]},"reference":[{"issue":"suppl 5","key":"9634_CR1","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 32(suppl 5):S112\u2013S119","journal-title":"Am J Kidney Dis"},{"key":"9634_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","volume":"58","author":"AK Cheung","year":"2000","unstructured":"Cheung AK, Sarnak MJ, Yan G et al (2000) Atherosclerotic cardiovascular disease risks in chronic haemodialysis patients. Kidney Int 58:353\u2013362","journal-title":"Kidney Int"},{"key":"9634_CR3","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1681\/ASN.V1271549","volume":"12","author":"GA Kaysen","year":"2001","unstructured":"Kaysen GA (2001) The microinflammatory State in Uremia: causes and potential consequences. J Am Soc Nephrol 12:1549\u20131557","journal-title":"J Am Soc Nephrol"},{"key":"9634_CR4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ndt\/gfh680","volume":"20","author":"EM Stuveling","year":"2005","unstructured":"Stuveling EM, Bakker SJL, Hillege HL et al (2005) Biochemical markers: a novel area for better prediction of renal risk? Nephrol Dial Transplant 20:497\u2013508","journal-title":"Nephrol Dial Transplant"},{"key":"9634_CR5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium\u00a0\u00d7\u00a0phosphorus product with mortality risk in chronic hemodialysis patients. Am J Kidney Dis 31:607\u2013617","journal-title":"Am J Kidney Dis"},{"key":"9634_CR6","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/ndt\/gfl118","volume":"21","author":"HH Jung","year":"2006","unstructured":"Jung HH, Kim S-W, Han H (2006) Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant 21:1915\u20131920","journal-title":"Nephrol Dial Transplant"},{"key":"9634_CR7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","volume":"73","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP, Ahmazadeh S, Anderson JE, Kalantar-Zadeh K (2008) Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 73:1296\u20131302","journal-title":"Kidney Int"},{"key":"9634_CR8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1053\/ajkd.2001.29222","volume":"38","author":"K Kalantar-Zadeh","year":"2001","unstructured":"Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH (2001) A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38:1251\u20131263","journal-title":"Am J Kidney Dis"},{"key":"9634_CR9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1525-139X.2002.00083.x","volume":"15","author":"P Stenvinkel","year":"2002","unstructured":"Stenvinkel P, Alvestrand A (2002) Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 15:329\u2013337","journal-title":"Semin Dial"},{"key":"9634_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfg513","volume":"19","author":"T Shoji","year":"2004","unstructured":"Shoji T, Shinohara K, Kimoto E et al (2004) Lower risk for cardiovascular mortality in oral 1\u03b1 hidroxy vitamin D3 users in a hemodialysis population. Nephrol Dial Transplant 19:179\u2013184","journal-title":"Nephrol Dial Transplant"},{"key":"9634_CR11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","volume":"16","author":"M Teng","year":"2005","unstructured":"Teng M, Wolf M, Ofsthun MN et al (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16:1115\u20131125","journal-title":"J Am Soc Nephrol"},{"key":"9634_CR12","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/er.2004-0002","volume":"26","author":"S Napgal","year":"2005","unstructured":"Napgal S, Na S, Rathnachalam R (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26:662\u2013687","journal-title":"Endocr Rev"},{"key":"9634_CR13","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/art.22722","volume":"56","author":"S Patel","year":"2007","unstructured":"Patel S, Farragher T, Berry J et al (2007) Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56:2143\u20132149","journal-title":"Arthritis Rheum"},{"key":"9634_CR14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","volume":"110","author":"YC Li","year":"2002","unstructured":"Li YC, Kong J, Wei M et al (2002) 1, 25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229\u2013238","journal-title":"J Clin Invest"},{"issue":"1","key":"9634_CR15","doi-asserted-by":"crossref","first-page":"E-125","DOI":"10.1152\/ajpendo.00224.2004","volume":"288","author":"W Xiang","year":"2005","unstructured":"Xiang W, Kong J, Chen S et al (2005) Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 288(1):E-125\u2013E-132","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9634_CR16","unstructured":"Achinger SG, Ayus JC (2005) The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl (95):S37\u201342"},{"issue":"12","key":"9634_CR17","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1681\/ASN.2006050520","volume":"17","author":"X Tan","year":"2006","unstructured":"Tan X, Li Y, Liu Y (2006) Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 17(12):3382\u20133393","journal-title":"J Am Soc Nephrol"},{"key":"9634_CR18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000065289","volume":"22","author":"JK O\u2019Herrin","year":"2002","unstructured":"O\u2019Herrin JK, Hullet DA, Heisy DM et al (2002) A retrospective evaluation of 1, 25-dihydroxyvitamin D (3) and its potential effects on renal allograft function. Am J Nephrol 22:515\u2013520","journal-title":"Am J Nephrol"},{"key":"9634_CR19","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","volume":"68","author":"R Agarwal","year":"2003","unstructured":"Agarwal R, Acharya M, Tian J et al (2003) Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int 68:2823\u20132828","journal-title":"Kidney Int"},{"key":"9634_CR20","first-page":"1383","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","unstructured":"Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin study (4S). Lancet 344:1383\u20131389","journal-title":"Lancet"},{"key":"9634_CR21","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0022-2275(20)41379-3","volume":"33","author":"A Endo","year":"1992","unstructured":"Endo A (1992) the discovery and development of HMG-CoA reductase inhibitors. J Lipid Res 33:1569\u20131582","journal-title":"J Lipid Res"},{"issue":"Suppl III","key":"9634_CR22","first-page":"III39","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon J (2004) Beneficial cardiovascular effects of statins. Circulation 109(Suppl III):III39\u2013III43","journal-title":"Circulation"},{"issue":"Suppl 1","key":"9634_CR23","first-page":"S76","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) NKF-K\/DOQI clinical practice guidelines for chronic kidney disease. Am J Kidney Dis 39(Suppl 1):S76\u2013S110","journal-title":"Am J Kidney Dis"},{"key":"9634_CR24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosh JP, Lewis JB, Greene T, Rogers N, Roth D (1999) For the Modification of Diet in Renal Disease Study Group: a more accurate method to estimate glomerular filtration rate from serum creatinine. A new prediction equation. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"9634_CR25","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/ndt\/14.7.1732","volume":"14","author":"K Kalantar-Zadeh","year":"1999","unstructured":"Kalantar-Zadeh K, Kleiner M, Dunne E et al (1999) A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant 14:1732\u20131738","journal-title":"Nephrol Dial Transplant"},{"issue":"4 suppl 3","key":"9634_CR26","first-page":"S52","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 suppl 3):S52\u2013S130","journal-title":"Am J Kidney Dis"},{"key":"9634_CR27","unstructured":"(2003) K\/DOQI Clinical practice guidelines for managing of dyslipidemias in patients with kidney disease. Am J Kidney Dis 41(suppl 3):39\u201358"},{"key":"9634_CR28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/ki.1995.22","volume":"47","author":"RN Foley","year":"1995","unstructured":"Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE (1995) Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 47:884\u2013890","journal-title":"Kidney Int"},{"key":"9634_CR29","unstructured":"US Renal Data System (2005) USRDS 2005 annual data report: morbidity and mortality. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda"},{"key":"9634_CR30","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","volume":"333","author":"J Shepherd","year":"1995","unstructured":"Shepherd J, Cobbe SM, Ford I et al (1995) For the West of Scotland coronary prevention study group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301\u20131307","journal-title":"N Engl J Med"},{"key":"9634_CR31","doi-asserted-by":"crossref","unstructured":"(1998) The long-term Intervention with pravastatin in ischemic disease (LIPID) study group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Eng J Med 339:1349\u20131357","DOI":"10.1056\/NEJM199811053391902"},{"key":"9634_CR32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner C, Krane V, M\u00e4rz W, Olschewski M, Mann JF, Ruf G, Ritz E (2005) German diabetes and dialysis study investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353:238\u2013248","journal-title":"N Engl J Med"},{"key":"9634_CR33","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.0000143892.84582.60","volume":"21","author":"M Tonelli","year":"2004","unstructured":"Tonelli M, Isles C, Curhan GC et al (2004) Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 21:1557\u20131563","journal-title":"Circulation"},{"key":"9634_CR34","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","volume":"360","author":"BC Fellstrom","year":"2009","unstructured":"Fellstrom BC, Jardine AG, Schiemedler E et al (2009) Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360:1395\u20131407","journal-title":"N Engl J Med"},{"key":"9634_CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2215\/CJN.01170905","volume":"2","author":"BD Bradbury","year":"2007","unstructured":"Bradbury BD, Fissell RB, Albert JM et al (2007) Predictors of early mortality among incident US Hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Clin J Am Soc Nephrol 2:89\u201399","journal-title":"Clin J Am Soc Nephrol"},{"key":"9634_CR36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.ki.5001685","volume":"71","author":"CP Kovesdy","year":"2007","unstructured":"Kovesdy CP (2007) Regional mortality differences in end-stage renal disease: how far can observational studies take us. Kidney Int 71:11\u201312","journal-title":"Kidney Int"},{"key":"9634_CR37","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/ndt\/15.10.1624","volume":"15","author":"P Stenvinkel","year":"2000","unstructured":"Stenvinkel P, Lindholm B, Heimb\u00fcrger M, Heimb\u00fcrger O (2000) Elevated serum levels of soluble adhesion molecules predicts death in predialysis patients: association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 15:1624\u20131630","journal-title":"Nephrol Dial Transplant"},{"key":"9634_CR38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.ajkd.2005.09.014","volume":"47","author":"H Honda","year":"2006","unstructured":"Honda H, Qureshi A, Heimb\u00fcrger O et al (2006) Serum albumin, C-reactive protein, interleukin-6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47:139\u2013148","journal-title":"Am J Kidney Dis"},{"key":"9634_CR39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfi224","volume":"21","author":"V Panichi","year":"2006","unstructured":"Panichi V, Paoletti V, Manterano E et al (2006) In vivo and in vitro effects of simvastatin on inflammatory markers in predialysis patients. Nephrol Dial Transplant 21:337\u2013344","journal-title":"Nephrol Dial Transplant"},{"key":"9634_CR40","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/01.ATV.0000163840.63685.0c","volume":"25","author":"C Arnaud","year":"2005","unstructured":"Arnaud C, Burger F, Steffens S et al (2005) Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins. Arterioscler Thromb Vasc Biol 25:1231\u20131236","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9634_CR41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000049041","volume":"90","author":"S T\u00fcrk","year":"2002","unstructured":"T\u00fcrk S, Akbulut M, Yildiz A et al (2002) Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: the effect on serum IL-1 and IL-6 levels and bone mineral density. Nephron 90:188\u2013194","journal-title":"Nephron"},{"key":"9634_CR42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diabres.2006.10.007","volume":"77","author":"A Giulietti","year":"2007","unstructured":"Giulietti A, van Etten E, Overbragh L et al (2007) Monocytes from type 2 diabetic patients have a pro-inflammatory profile 1, 25-dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 77:47\u201357","journal-title":"Diabetes Res Clin Pract"},{"key":"9634_CR43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1523-1755.2002.00109.x","volume":"61","author":"SL Seliger","year":"2002","unstructured":"Seliger SL, Weiss NS, Gillen DL et al (2002) HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 61:297\u2013304","journal-title":"Kidney Int"},{"key":"9634_CR44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(06)68971-X","volume":"368","author":"DS Grimes","year":"2006","unstructured":"Grimes DS (2006) Are statins analogues of vitamin D? Lancet 368:83\u201386","journal-title":"Lancet"},{"key":"9634_CR45","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.amjcard.2006.11.036","volume":"99","author":"JL P\u00e9rez-Castrill\u00f3n","year":"2007","unstructured":"P\u00e9rez-Castrill\u00f3n JL et al (2007) Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 99:903\u2013905","journal-title":"Am J Cardiol"},{"key":"9634_CR46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2007.110","volume":"168","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K (2008) Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 168:397\u2013403","journal-title":"Arch Intern Med"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-009-9634-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9634-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T14:28:30Z","timestamp":1633876110000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-009-9634-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,11]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["9634"],"URL":"https:\/\/doi.org\/10.1007\/s11255-009-9634-x","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,11]]}}}